![group of people](/system/files/styles/mdc_list_teaser_mdc_mobile_1_5x/private/2024-05/captain-t-cell.jpg?h=bc1cd50e&itok=tvO6PU8v)
Captain T Cell secures seed financing round
Captain T Cell, a spin-off from the Max Delbrück Center, raised €8.5 million in startup funding. The startup focuses on developing T cells to target solid tumors. The funds are intended to move a new generation of T cell therapies towards the clinic.